SynCardia Systems, a developer and manufacturer of temporary implantable artificial hearts, filed on Monday with the SEC to raise up to $40 million in an initial public offering.
The Tucson, AZ-based company, which was founded in 2001 and booked $18 million in sales for the 12 months ended June 30, 2015, plans to list on the Nasdaq under the symbol TAHT. Roth Capital is the sole bookrunner on the deal. No pricing terms were disclosed.
